SobiESG & Sustainability Jobs

Biopharmaceutical company focused on rare diseases, developing innovative therapies to improve the lives of patients with complex health needs.

Sobi (Swedish Orphan Biovitrum) is a global biopharmaceutical company headquartered in Stockholm. It develops and commercialises medicines for rare diseases, with therapies concentrated in haematology (haemophilia, ITP, PNH, DLBCL), immunology (FMF, CAPS, HLH, Still's disease), and specialty care. The company works across the full pipeline-to-patient journey and runs access programmes and humanitarian aid initiatives to reach patients in lower-resource settings.

Why it matters

Sobi's sustainability angle sits at the intersection of access and environment. On the social side, only around 5% of rare diseases have approved treatments, and Sobi frames expanding patient access - including managed access programmes and humanitarian aid - as a core part of its mission. On the environmental side, the company has set science-based climate targets, is increasing its use of renewable electricity, and is transitioning to fossil-free car fleets across several countries.

Sobi operates globally with its head office in Stockholm and reports sustainability performance through formal governance structures, a published Code of Conduct, and transparency disclosures on payments to healthcare professionals.